To evaluate the clinicopathological and prognostic significance of FilGAP expression, FilGAP scores were divided into two categories (high and low) on the basis of the mean + SD values (9, 9, 11, and 3 in FL, GCB-type DLBCL, non-GCB-type DLBCL, and TCL, respectively) as the cut-off. This evidence concerns the gene ARHGAP24 and diffuse large B-cell lymphoma.